BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 31482072)

  • 1. Evolutionary and Structural Overview of Human Picornavirus Capsid Antibody Evasion.
    Cifuente JO; Moratorio G
    Front Cell Infect Microbiol; 2019; 9():283. PubMed ID: 31482072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-like particles in picornavirus vaccine development.
    Dong H; Guo HC; Sun SQ
    Appl Microbiol Biotechnol; 2014 May; 98(10):4321-9. PubMed ID: 24647496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune evasion by picornaviruses.
    Zhang X; Paget M; Wang C; Zhu Z; Zheng H
    Eur J Immunol; 2020 Sep; 50(9):1268-1282. PubMed ID: 32767562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Globally defining the effects of mutations in a picornavirus capsid.
    Mattenberger F; Latorre V; Tirosh O; Stern A; Geller R
    Elife; 2021 Jan; 10():. PubMed ID: 33432927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human picornaviruses associated with neurological diseases and their neutralization by antibodies.
    Anastasina M; Domanska A; Palm K; Butcher S
    J Gen Virol; 2017 Jun; 98(6):1145-1158. PubMed ID: 28631594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of human rhinovirus immunogenic epitopes for rational vaccine design.
    Stepanova E; Isakova-Sivak I; Rudenko L
    Expert Rev Vaccines; 2019 Sep; 18(9):877-880. PubMed ID: 31416365
    [No Abstract]   [Full Text] [Related]  

  • 7. Parvovirus Capsid Structures Required for Infection: Mutations Controlling Receptor Recognition and Protease Cleavages.
    Callaway HM; Feng KH; Lee DW; Allison AB; Pinard M; McKenna R; Agbandje-McKenna M; Hafenstein S; Parrish CR
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The conserved N-terminus of human rhinovirus capsid protein VP4 contains membrane pore-forming activity and is a target for neutralizing antibodies.
    Panjwani A; Asfor AS; Tuthill TJ
    J Gen Virol; 2016 Dec; 97(12):3238-3242. PubMed ID: 27902347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and suppression of innate antiviral responses by picornaviruses.
    Feng Q; Langereis MA; van Kuppeveld FJ
    Cytokine Growth Factor Rev; 2014 Oct; 25(5):577-85. PubMed ID: 25086453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Picornaviruses and Apoptosis: Subversion of Cell Death.
    Croft SN; Walker EJ; Ghildyal R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune Interactions.
    Grueso E; Sánchez-Martínez C; Calvo-López T; de Miguel FJ; Blanco-Menéndez N; Fernandez-Estevez M; Elizalde M; Sanchez J; Kourani O; Martin D; Tato A; Guerra M; Andrés G; Almendral JM
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Picornavirus subversion of the autophagy pathway.
    Klein KA; Jackson WT
    Viruses; 2011 Sep; 3(9):1549-61. PubMed ID: 21994795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Antiviral Immune Response through Recognition of the Repeating Subunit Pattern of Viral Capsids Is Toll-Like Receptor 2 Dependent.
    Shepardson KM; Schwarz B; Larson K; Morton RV; Avera J; McCoy K; Caffrey A; Harmsen A; Douglas T; Rynda-Apple A
    mBio; 2017 Nov; 8(6):. PubMed ID: 29138299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Picornavirus and enterovirus diversity with associated human diseases.
    Tapparel C; Siegrist F; Petty TJ; Kaiser L
    Infect Genet Evol; 2013 Mar; 14():282-93. PubMed ID: 23201849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral and host proteins involved in picornavirus life cycle.
    Lin JY; Chen TC; Weng KF; Chang SC; Chen LL; Shih SR
    J Biomed Sci; 2009 Nov; 16(1):103. PubMed ID: 19925687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chickens host diverse picornaviruses originated from potential interspecies transmission with recombination.
    Lau SKP; Woo PCY; Yip CCY; Li KSM; Fan RYY; Bai R; Huang Y; Chan KH; Yuen KY
    J Gen Virol; 2014 Sep; 95(Pt 9):1929-1944. PubMed ID: 24906980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avian picornaviruses: molecular evolution, genome diversity and unusual genome features of a rapidly expanding group of viruses in birds.
    Boros Á; Pankovics P; Reuter G
    Infect Genet Evol; 2014 Dec; 28():151-66. PubMed ID: 25278047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a short, highly conserved, motif required for picornavirus capsid precursor processing at distal sites.
    Kristensen T; Belsham GJ
    PLoS Pathog; 2019 Jan; 15(1):e1007509. PubMed ID: 30657784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Basis for Escape of Human Astrovirus from Antibody Neutralization: Broad Implications for Rational Vaccine Design.
    Bogdanoff WA; Perez EI; López T; Arias CF; DuBois RM
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody recognition of picornaviruses and escape from neutralization: a structural view.
    Mateu MG
    Virus Res; 1995 Sep; 38(1):1-24. PubMed ID: 8546007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.